TELA Bio, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-108.2M | $11.3M |
| FY2018 | — | $-137.9M | $17.3M |
| FY2019 | $30.2M | $31.0M | $45.3M |
| FY2020 | $30.8M | $49.0M | $74.4M |
| FY2021 | $31.5M | $20.1M | $43.9M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2017 | — | $-108.2M | $11.3M |
| FY2018 | — | $-137.9M | $17.3M |
| FY2019 | $30.2M | $31.0M | $45.3M |
| FY2020 | $30.8M | $49.0M | $74.4M |
| FY2021 | $31.5M | $20.1M | $43.9M |